Juncture Wealth Strategies’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$252K Sell
3,216
-295
-8% -$23.8K 0.07% 162
2026
Q1
$304K Buy
3,511
+880
+33% +$84.3K 0.1% 108
2025
Q4
$253K Sell
2,631
-1,302
-33% -$126K 0.08% 118
2025
Q3
$375K Buy
3,933
+567
+17% +$52.1K 0.13% 88
2025
Q2
$293K Hold
3,366
0.1% 99
2025
Q1
$302K Sell
3,366
-100
-3% -$8.95K 0.12% 102
2024
Q4
$277K Sell
3,466
-167
-5% -$14.5K 0.1% 111
2024
Q3
$327K Buy
3,633
+400
+12% +$33.6K 0.13% 95
2024
Q2
$254K Buy
+3,233
New +$265K 0.11% 91

Other funds holding MDT

Juncture Wealth Strategies's MDT Position: Q2 2026 in Review

Juncture Wealth Strategies reduced its Medtronic (MDT) stake by 8.4% in Q2 2026, selling an estimated $23.8K and leaving 3,216 shares worth $252K. The position accounts for 0.07% of the portfolio, ranked #162.

Juncture Wealth Strategies first reported a position in MDT in Q2 2024 and has held it in 9 quarters since. The position peaked at $375K in Q3 2025. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Juncture Wealth Strategies held 3,216 shares of Medtronic worth $252K as of Q2 2026.
  • Juncture Wealth Strategies sold 295 Medtronic shares in Q2 2026, an estimated $23.8K.
  • Medtronic made up 0.07% of Juncture Wealth Strategies's portfolio in Q2 2026, its #162 holding.
  • Juncture Wealth Strategies first reported a position in Medtronic in Q2 2024 and has held it in 9 quarters since.
  • Juncture Wealth Strategies's Medtronic position peaked at $375K in Q3 2025.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Juncture Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.